Results for “”

Entry Author Date Location
Roche Enlists Dyno to Bring AI to Next-Generation Liver, CNS Gene Therapies 10/14/20 Boston
“Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug 10/12/20 New York
FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats 10/09/20 Europe
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More 10/09/20 National
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries 10/01/20 Europe
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug 09/30/20 New York
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins 09/29/20 Europe
Freeline Therapeutics Promotes Corbau to Chief Scientific Officer 09/28/20 Europe
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders 09/23/20 San Diego
Tau-Targeting Alzheimer’s Drug from AC Immune, Roche Fails in Phase 2 09/23/20 Europe
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/21/20 Boston
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series 09/16/20 Boston
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Silence Therapeutics Taps Orchard’s Mark Rothera as President & CEO 09/14/20 Europe
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest 09/08/20 San Francisco
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures 09/05/20 Boston
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Nestlé to Swallow Up Peanut Allergy Drug Maker Aimmune in $2.6B Deal 08/31/20 San Francisco
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Page 1 of 7 next page »